Rita Kachru, MD
Accepting new patients

Rita Kachru, MD

(she/her)
  • Allergy and Immunology
Average rating: 4.9
| 66 ratings
 
Santa Monica Allergy & Immunology | 1245 16th Street, Suite 303, Santa Monica, CA 90404

Languages

English, Spanish

Education

Medical Board Certification

Allergy and Immunology, American Board of Allergy and Immunology, 2005

Fellowship

Allergy & Immunology, LAC + USC Medical Center, 2005

Residency

Internal Medicine, Albany Medical Center Hospital, 2000

Internship

Internal Medicine, Albany Medical Center Hospital, 1997

Degree

MD, Medical College of Wisconsin, 1996

Recognitions

Locations

Santa Monica

Santa Monica Allergy & Immunology

Allergy and Immunology| Pediatric Allergy and Immunology

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Research

Interests

  • Food Allergy
  • Oral Immunotherapy
  • Atopic Dermatitis
  • Eosinophilic Esophagitis

Publications

  1. Kachru R. (September 2020). Psychosocial Issues and Quality of Life Associated with Food Allergy. Journal of Food Allergy. Food Allergy Primer, 2(1), 95-98
  2. Kachru R, Lim K, Anderson L. (2020). The Role of Biologics and Precision Based Medicine in Treating Atopic Diseases in Children. Current Treatment Options Allergy, 7, 312-325
  3. Palisade Group of Clinical Investigators, Kachru R. (November 2018). AR101 Oral Immunotherapy for Peanut Allergy. New England Journal of Medicine, 379(21), 1991-2001
  4. Kohn L, Kachru R. (February 2019). Management Dilemma: Initial Treatment for Newly Diagnosed SLE complicated by Corticosteroid Allergy. J Allergy Clin Immunol., 143(2), Supplement p1A-4A; AB1-440.
  5. Peng T, Wang V, Kachru R. (February 2017). Retrospective Review of Clinical Outcomes Post Physician-Supervised Negative Oral Baked Egg Challenge.  J Allergy Clin Immunol., 139(2), Supplement
  6. Corren J, Kachru R.  (2016). Relationship between nonallergic airway disease and asthma. In J. N. Baraniuk, and D. Shusterman (Eds.). Nonallergic rhinitis: Clinical Allergy and Immunology, book 19 (pp. 100-114). CRC Press.
  7. Bundy V, Geng B, Kachru R, Garcia-Lloret M. (November 2014). IgG4-Related Disease in a patient with allergic rhinitis, eosinophilia and chronic urticaria. J Allergy Clin Immunol., 113(5), A15
  8. Corren J, Kachru R. (2007). Relationship between nonallergic upper airway disease and asthma, Clin Allergy Immunol., 19, 101-14
  9. Kachru R, Morphew T, Kehl S, Jones C. (January 2007). Validation of a single survey that can be used for case identification and assessment of asthma control: The Breathmobile Program. Annals of Allergy, Asthma and Immunol., 97(6), 775-83
  10. Kachru R, Corren J. (January 2007). Characteristics of Chronic Rhinitis in Children. J Allergy Clin Immunol., 119(1)

In the News

Dr. Kachru has appeared on:

  • The Doctors
  • The Ricki Lake Show
  • NBC Nightly News with Lestor Holt

Dr. Kachru has been a medical consultant for:

  • LA Times
  • LA Parent Magazine
  • Medscape
  • Undark
  • KPCC

Insurance

  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • L.A. Care
  • Medicare Advantage
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • TRICARE
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.

Recognitions

  • Top Doctors, Los Angeles Magazine, 2024
  • Super Doctors® Southern California, 2020 - 2024
  • Top Doctors, Los Angeles Magazine, 2021, 2022, 2023
  • Food Allergy Research Education Clinical Care Network, 2015 - present, Principal Investigator
  • Genentech, Open Label Extension Study of Omalizumab in patients with Chronic Rhinosinusitis with Nasal Polyps, (Apr 2018 – Nov 2018), Principal Investigator
  • Aimmune Therapeutics, Real World AR101 Market Supporting Experience Study in Peanut-Allergic Children Ages 4 to 17 years old, (2017 – 2018), Principal Investigator
  • Aimmune Therapeutics, Peanut Oral Immunotherapy Study of AR101 For Desensitization in Children and Adults (PALISADES) (2015 - 2017), Principal Investigator